According to Santen Pharmaceutical 's latest financial reports the company's current earnings (TTM) are $0.28 B. In 2022 the company made an earning of $26.44 M a decrease over its 2021 earnings that were of $0.10 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.28 B | 996.55% |
2022 | $26.44 M | -75.14% |
2021 | $0.10 B | -65.28% |
2020 | $0.30 B | -18.35% |
2019 | $0.37 B | -4.37% |
2018 | $0.39 B | 22.65% |
2017 | $0.31 B | 0.6% |
2016 | $0.31 B | -55.76% |
2015 | $0.71 B | 164.91% |
2014 | $0.27 B | -3.69% |
2013 | $0.28 B | -11.62% |
2012 | $0.31 B | -19.83% |
2011 | $0.39 B | 29.29% |
2010 | $0.30 B | 1.35% |
2009 | $0.30 B |